Complete response and prolonged disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6

Authors

Gayathri Nagaraj, Washington University School of Medicine in St. Louis
Yousef Zarbalian, Washington University School of Medicine in St. Louis
Karin Flora, Washington University School of Medicine in St. Louis
Benjamin R. Tan Jr., Washington University School of Medicine in St. Louis

Journal

Journal of Gastrointestinal Oncology

Publication Date

2014

Volume

5

Issue

1

Inclusive Pages

E1-6

Document Type

Open Access Publication

DOI

10.3978/j.issn.2078-6891.2013.038

Rights and Permissions

Nagaraj G, Zarbalian Y, Flora K, Tan BR Jr. Complete response and prolonged disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6. J Gastrointest Oncol 2014;5(1):E1-E6. doi: 10.3978/j.issn.2078-6891.2013.038

Recommended Citation

Nagaraj, Gayathri; Zarbalian, Yousef; Flora, Karin; and Tan, Benjamin R. Jr., "Complete response and prolonged disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6." Journal of Gastrointestinal Oncology. 5, 1. E1-6. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/2156